We demonstrate persistent linear dose–response relationships between ALT/AST ratio, BUN or BUN/Cr ratio levels, and depression risk in elderly inpatients, remaining robust after rigorous adjustment for metabolic-inflammatory confounders. This evidence concerns the gene GPT and major depressive disorder.